A study of AZD3514 for prostate cancer that has spread and is no longer responding to hormone therapy
Cancer type:
Status:
Phase:
This study looked at a drug called AZD3514 for prostate cancer.
It was for men with prostate cancer that had spread to another part of the body and was no longer responding to hormone therapy.
More about this trial

- find the highest safe dose of AZD3514
- see if it slows the growth of prostate cancer that is no longer responding to hormone therapy
- learn more about the side effects
- find out more about AZD3514 and what happened to it in the body
- see if it was safe to have AZD3514 with a drug called abiraterone
Summary of results
- feeling sick
- being sick
- tiredness
- lack of energy
- loss of appetite
- indigestion
- diarrhoea
- constipation

Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Chief Investigator
Dr T. Elliott
Supported by
AstraZeneca
Experimental Cancer Medicine Centre (ECMC)
If you have questions about the trial please contact our cancer information nurses
Freephone 0808 800 4040